within Pharmacolibrary.Drugs.ATC.N;

model N02BE05
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 8.499999999999999e-05,
    adminDuration  = 600,
    adminMass      = 2000 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.00095,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>N02BE05</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Propacetamol is a prodrug of paracetamol (acetaminophen), designed for intravenous use to provide analgesic and antipyretic effects. It is hydrolyzed rapidly to paracetamol in the body. Propacetamol was used primarily in hospital settings, especially when oral or rectal administration was not feasible. It is not widely used today, having been largely replaced by intravenous formulations of paracetamol itself.</p><h4>Pharmacokinetics</h4><p>Healthy adult subjects, after single intravenous dose of propacetamol (converted to paracetamol PK parameters, as propacetamol itself is rapidly hydrolyzed).</p><h4>References</h4><ol><li><p>Sartini, I, et al., &amp; Giorgi, M (2022). Propacetamol in dogs: First description of its pharmacokinetics after intravenous and oral administration. <i>Research in veterinary science</i> 144 11–17. DOI:<a href=&quot;https://doi.org/10.1016/j.rvsc.2022.01.002&quot;>10.1016/j.rvsc.2022.01.002</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/35033846/&quot;>https://pubmed.ncbi.nlm.nih.gov/35033846</a></p></li><li><p>Allegaert, K, et al., &amp; Devlieger, H (2004). Pharmacokinetics of single dose intravenous propacetamol in neonates: effect of gestational age. <i>Archives of disease in childhood. Fetal and neonatal edition</i> 89(1) F25–F28. DOI:<a href=&quot;https://doi.org/10.1136/fn.89.1.f25&quot;>10.1136/fn.89.1.f25</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/14711849/&quot;>https://pubmed.ncbi.nlm.nih.gov/14711849</a></p></li><li><p>Prins, SA, et al., &amp; Mathot, RA (2008). Pharmacokinetics and analgesic effects of intravenous propacetamol vs rectal paracetamol in children after major craniofacial surgery. <i>Paediatric anaesthesia</i> 18(7) 582–592. DOI:<a href=&quot;https://doi.org/10.1111/j.1460-9592.2008.02619.x&quot;>10.1111/j.1460-9592.2008.02619.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/18482233/&quot;>https://pubmed.ncbi.nlm.nih.gov/18482233</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end N02BE05;
